COMMUNIQUÉS West-GlobeNewswire

Xbrane Biopharma largest shareholder Serendipity Group issues a credit facility of SEK 50 million to the company
22/12/2017
Press release 2017-12-22 Xbrane Biopharma AB (publ) ("Xbrane" or the "Company") has today got issued a credit facility from Serendipity Group AB ("Serendipity Group") of SEK 50 million (the "Credit Facility"). The [...]
Saniona AB: The Nomination Committee of Saniona Proposes Election of Two Additional Members of the Board of Directors
22/12/2017
PRESS RELEASE December 22, 2017 Saniona, a leading biotech company in the field of ion channels, today announced that its Nomination Committee comprised of Søren Skjærbæk appointed by Jørgen Drejer, John Haurum [...]
Novartis' combination therapy Tafinlar® + Mekinist® granted FDA Priority Review for the adjuvant treatment of stage III BRAF V600 mutation-positive melanoma
22/12/2017
Priority Review designation based on Phase III study showing 53% reduction in risk of recurrence or death with Tafinlar + Mekinist, as compared to placebo[1] Improvements observed in key secondary endpoints including [...]
Bank of America Merrill Lynch Investment Banking Veteran Joins Hua Medicine as CFO
22/12/2017
SHANGHAI, China, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Hua Medicine, a leading clinical stage biotechnology company based in Shanghai, announced George Lin, a seasoned investment banker in the U.S. and Asia, joins Hua [...]
DiaMedica Therapeutics Announces Results of Annual General and Special Meeting of Shareholders
22/12/2017
MINNEAPOLIS, Dec. 21, 2017 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (TSX-V: DMA ) (OTCQB:DMCAF) (the “ Company ”), today announced that at its Annual General and Special Meeting (the “ Meeting ”) of shareholders [...]
La Jolla Pharmaceutical Company Announces FDA Approval of Giapreza™ (angiotensin II)
22/12/2017
Giapreza increases blood pressure in adults with septic or other distributive shock La Jolla to host conference call and webcast at 8:30 a.m. EST on December 22, 2017 SAN DIEGO, Dec. 21, 2017 (GLOBE NEWSWIRE) -- La [...]
Forward Pharma Files Final Brief in its Appeal of the U.S. Patent Interference to the Federal Circuit
21/12/2017
COPENHAGEN, Denmark, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ: FWP ) (“Forward” or the “Company”) today announced the filing of its reply brief to the U.S. Court of Appeals for the Federal Circuit ( [...]
Akers Biosciences Announces Closing of $6,900,000 Public Offering
21/12/2017
THOROFARE, N.J., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or “Akers Bio”), a developer of rapid health information technologies, today announces the closing [...]
Proteostasis Therapeutics Announces Completion of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
21/12/2017
CAMBRIDGE, Mass., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (Nasdaq: PTI ), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to [...]
Humanigen Signs Definitive Agreements to Exchange Loan Obligations for Equity
21/12/2017
Transactions Create Biotechnology Company Focused on Immunotherapy and Oncology Lenzilumab Begins Development for Treating Key Side-Effects Associated with CAR-T BRISBANE, Calif., Dec. 21, 2017 (GLOBE NEWSWIRE) -- [...]
Integra LifeSciences to Present at the 36th Annual J.P. Morgan Healthcare Conference
21/12/2017
PLAINSBORO, N.J., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART ), a leading global medical technology company, today announced President and Chief Executive Officer Peter [...]
Ascendis Pharma A/S Announces Participation in 36th Annual J.P. Morgan Healthcare Conference
21/12/2017
COPENHAGEN, Denmark, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND ), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare [...]
Fluidigm Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21/12/2017
SOUTH SAN FRANCISCO, Calif., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced that the Compensation Committee of its Board of Directors, which is comprised entirely of independent [...]
ZIOPHARM to Present at the 36th Annual J.P. Morgan Healthcare Conference
21/12/2017
BOSTON, Dec. 21, 2017 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the 36 th Annual J.P. Morgan Healthcare [...]
GenMark Diagnostics to Present at the J.P. Morgan 36th Annual Healthcare Conference
21/12/2017
CARLSBAD, Calif., Dec. 21, 2017 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK ), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that President and Chief [...]
Altimmune to Participate in the 10th Annual Biotech Showcase in San Francisco, January 8 – 10, 2018
21/12/2017
GAITHERSBURG, Md., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage immunotherapeutics company, announced today that Bill Enright, President and Chief Executive Officer, will provide a [...]
Antares Pharma Provides XYOSTED™ Regulatory Update
21/12/2017
EWING, N.J., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) today announced that a written request for a Type A meeting, along with a comprehensive briefing document, have been submitted to the U [...]
ProPhase Labs, Inc. Announces Final Results of Its Tender Offer
21/12/2017
DOYLESTOWN, Pa., Dec. 21, 2017 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH ) ( www.ProPhaseLabs.com ), a diversified natural health medical science company (“ProPhase”), announced today the final results of [...]
BriaCell Announces Closing of Warrant Incentive Program
21/12/2017
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER U.S. NEWSWIRE SERVICES BERKELEY, Calif. and VANCOUVER, British Columbia, Dec. 21, 2017 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (" BriaCell " or the " Company [...]

Pages